National Research Corporation Announces First Quarter 2015

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
National Research Corporation Announces First Quarter 2015 Results

LINCOLN, Neb., May 07, 2015 (GLOBE NEWSWIRE) -- National Research Corporation (Nasdaq: NRCIA ) (Nasdaq: NRCIB ) today announced results for the first quarter of 2015.

  • Net New Sales $5.0 million, up 52%
  • Total Contract Value $105.8 million
  • Revenue up 1% to $26.3 million
  • Net Income of $3.5 million, down 36%

Remarking on Company performance, Michael D. Hays, chief executive officer of National Research Corporation said, “The consumer-facing side of healthcare is evolving quickly, resulting in rapid adoption of NRC’s most innovative offerings. Industry leaders such as Intermountain Healthcare, Kaiser Permanente, Cedars-Sinai, Sentra and Cleveland Clinic are setting a new bar for Customer-Centric Healthcare Across the Continuum.”

Revenue for the quarter ended March 31, 2015, was $26.3 million, compared to $26.0 million for the same quarter in 2014. Net income for the quarter ended March 31, 2015, was $3.5 million, compared to $5.5 million for the quarter ended March 31, 2014. Diluted earnings per share decreased to $0.08 for Class A shares and $0.49 for Class B shares for the quarter ended March 31 2015, from diluted earnings per share of $0.13 for Class A shares and $0.77 for Class B shares for the quarter ended March 31, 2014. Combined diluted earnings per share (a non-GAAP measure) decreased to $0.14 for the quarter ended March 31, 2015, from $0.22 for the first quarter of 2014.       

Regarding first quarter performance, Kevin Karas, chief financial officer of National Research Corporation, said, “We continued the trend of positive quarterly net new sales momentum with a 52% increase over prior year.  Organic revenue growth from new contracts was offset primarily by a significant reduction in revenue from lower health risk assessment volumes as well as the impact from 2014 contract value reductions, with some shift of revenue into future quarters.  Acquisition related expenses and investments to support rapidly growing offerings also increased in the quarter, resulting in a 36% decrease in net income compared to the same period last year.”

A listen-only simulcast of National Research Corporation’s 2015 first quarter conference call will be available online at http://edge.media-server.com/m/p/ck9idxkm on May 8, 2015, beginning at 11:00 a.m. Eastern time.  The online replay will follow approximately one hour later and continue for 30 days.

For more than 34 years, National Research Corporation has been at the forefront of patient-centered care, helping healthcare providers measure and improve quality and services through analytics that offer a rich understanding of customers’ experiences, preferences, risks and behaviors across the healthcare continuum.

The information discussed within this release includes financial results and projections that are in accordance with accounting principles generally accepted in the United States (GAAP). In addition, certain non-GAAP financial measures have been provided that calculate combined earnings per share based on combined Class A and Class B shares and share equivalents outstanding, respectively. The non-GAAP measures should be read in conjunction with the corresponding GAAP measures and should be considered in addition to, and not as an alternative or substitute for, the measures prepared in accordance with GAAP. Please note that the Company’s non-GAAP measures may be different than those used by other companies.  The additional non-GAAP financial information the Company presents should be considered in conjunction with, and not as a substitute for, the Company’s financial information presented in accordance with GAAP.  The non-GAAP financial measures are provided in an effort to provide information that investors may deem relevant to evaluate results from the company's core business operations and to compare the company's performance with prior periods.  The company uses both GAAP and these non-GAAP financial measures for evaluating comparable financial performance against prior periods. 

This press release includes “forward-looking” statements related to the Company that can generally be identified as describing the Company’s future plans, objectives or goals.  Such forward-looking statements are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated.  These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  For further information about the factors that could affect the Company’s future results, please see the Company’s filings with the Securities and Exchange Commission.

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY
Unaudited Condensed Consolidated Statements of Income
(In thousands, except per share data)
   Three months ended    March 31,  
       2015        2014   
     
Revenue $   26,270   $   26,030  
     
Operating expenses:    
Direct   11,799     10,329  
Selling, general and administrative   7,627     6,366  
Depreciation and amortization     1,015       935  
  Total operating expenses     20,441       17,630  
     
  Operating income   5,829     8,400  
     
Other income (expense):    
  Interest income   17     17  
  Interest expense   (63 )   (81 )
  Other, net     (1 )     7  
     
  Total other expense     (47 )     (57 )
     
  Income before income taxes   5,782     8,343  
     
Provision for income taxes     2,302       2,890  
     
   Net income $   3,480   $   5,453  
     
Earnings Per Share of Common Stock:    
  Basic Earnings Per Share:    
  Class A $     0.08   $     0.13  
  Class B $     0.50   $     0.79  
  Diluted Earnings Per Share:    
  Class A $   0.08   $   0.13  
  Class B $   0.49   $   0.77  
     
Weighted average shares and share equivalents outstanding   Class A - basic     20,792       20,742  
  Class B - basic      3,478        3,469  
  Class A - diluted     21,033       21,134  
  Class B - diluted      3,524        3,541  

 

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY
Unaudited Condensed Consolidated Balance Sheets
(Dollars in thousands, except per share amounts and par value)
    Mar. 31,   Dec. 31,
    2015     2014  
ASSETS  
Current Assets:  
Cash and cash equivalents $   37,010   $   40,042  
Accounts receivable, net   11,804     8,116  
Income taxes receivable   604     1,100  
Other current assets   3,753     3,930  
Total current assets   53,171     53,188  
 
Property and equipment, net   11,604     12,143  
Goodwill   58,280     58,489  
Other, net   5,397     5,690  
Total Assets $   128,452   $   129,510  
 
LIABILITIES AND SHAREHOLDERS’ EQUITY  
 
Current Liabilities:  
Accounts payable and accrued expenses $   5,742   $   6,028  
Deferred revenue   15,483     15,095  
Accrued compensation   4,023     4,365  
Income taxes payable --   110  
Notes payable   2,346     2,328  
Total Current Liabilities   27,594     27,926  
 
Non-current liabilities   13,015     13,836  
 
Total Liabilities   40,609     41,762  
 
Shareholders’ Equity:  
Preferred stock, $0.01 par value, authorized 2,000,000 shares,  none issued -- --
Class A Common stock, $0.001 par value; authorized 60,000,000 shares, issued 25,538,056 in 2015 and 25,475,662 in 2014, outstanding 20,939,430 in 2015 and 20,894,286 in 2014    25     25  
Class B Common stock, $0.001 par value; authorized 80,000,000 shares, issued 4,262,287 in 2015 and 4,251,889 in 2014, outstanding 3,502,644 in 2015 and 3,494,865 in 2014   4     4  
Additional paid-in capital   45,370     44,864  
Retained earnings   74,649     73,686  
Accumulated other comprehensive loss     (1,827 )     (773 )
Treasury stock     (30,378 )     (30,058 )
Total shareholders’ equity   87,843     87,748  
Total liabilities and shareholders’ equity $   128,452   $   129,510  
 
NATIONAL RESEARCH CORPORATION AND SUBSIDIARY
Unaudited Non-GAAP Combined Earnings Per Share Schedule
(In thousands, except per share data)
  Three months ended    March 31,  
     2015        2014   
  Combined Earnings Per Share    
  Basic Earnings Per Share $   0.14   $   0.23  
  Diluted Earnings Per Share $   0.14   $     0.22  
  Combined weighted average shares and share equivalents outstanding            
  Combined - Basic     24,270     24,211  
  Combined - Diluted      24,557        24,676  

 

Kevin R. Karas Chief Financial Officer 402-475-2525

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 18

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 200

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 95

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 29

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
Teledyne LeCroy Drives AI Scale-up with New UALink

Updated Category News Views 17

Pushing the Boundaries of AI Infrastructure Teledyne LeCroy is shaking things up with their latest innovation—the Xena Z2244 Ultra Accelerator Link™ Traffic Generator, a tool that promises to turbocharge validation systems for AI and HPC scale-up infrastructure. If you're dealing with the nuts and bolts of next-gen networks, this one's worth your attention. Setting a...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 136

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 177

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 283

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 62

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Kelly Munson Takes Charge as President and CEO of Independence Health Group

Updated Category News Views 574

Kelly Munson Appointed President and CEO Independence Health Group proudly announces that Kelly A. Munson will take the role of President and Chief Executive Officer. Beginning this new chapter, she will bring with her a wealth of experience and insight derived from her tenure with AmeriHealth Caritas, which operates under the Independence Health Group umbrella....

Continue Reading
Seek AI Achieves Dual Patents, Pioneering AI Data Workflows

Updated Category News Views 201

Innovative Patents Transforming AI Data Analytics NEW YORK-- Seek AI, the agentic AI platform designed for the modern data stack, proudly announces the acquisition of two groundbreaking patents. Awarded by the United States Patent and Trademark Office (USPTO), these patents highlight Seek AI's unique approach to human-in-the-loop workflows that utilize LLM-generated...

Continue Reading
InMed Pharmaceuticals Tackles Nasdaq Compliance Challenges

Updated Category News Views 95

InMed Pharmaceuticals Faces Nasdaq Compliance Challenge InMed Pharmaceuticals Inc. (NASDAQ: INM), a biopharmaceutical firm recognized for its innovative drug development, is actively addressing a delisting notice from Nasdaq, which is due to not meeting minimum bid price regulations. The company has formally initiated an appeal to the Nasdaq Listing Qualifications Panel...

Continue Reading
Tetragon Financial Group Investor Call Highlights and Insights

Updated Category News Views 139

Join Tetragon Financial Group for a Special Investor Call Tetragon Financial Group Limited will be hosting an important investor call to provide key updates about the company. Set for Wednesday, March 5, at 15:30 GMT / 10:30 EST, this call is a significant opportunity for investors to gain insights into Tetragon's annual report and overall company performance. What to...

Continue Reading
Exploring the Future of Bleeding Disorders Treatment Market

Updated Category News Views 214

Growing Landscape of the Bleeding Disorders Treatment Market The Bleeding Disorders Treatment Market is on a significant growth trajectory as it adapts to the rising global prevalence of conditions like hemophilia and other rare coagulation disorders. This upward trend is supported by remarkable advancements in treatment options, increasing healthcare funding, and rising...

Continue Reading